Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has enclosed copies of newspaper advertisement of the financial results of the company for the fourth quarter and financial year ended March 31, 2024, as published in Business Standard and Nava Telangana on May 27, 2024.
The above information is a part of company’s filings submitted to BSE.